GST Benefits New Revised MRP, 100% GST benefit passed
Notify Me
Abbott Healthcare Pvt Ltd

Aggribloc Injection 100ml

Blood Clot
MRP ₹10,150.67 (Inclusive of all taxes)
Deliver to

    Netmeds First Membership

    Starting at just ₹[] for 3 months.
    View Plans

    Introduction About AGGRIBLOC INJECTION

    AGGRIBLOC INJECTION contains Tirofiban which belongs to the group of medicines called Platelet Aggregation Inhibitors. It is used to assist the blood flow to the heart and manage chest pain and heart attacks. It may also be used in patients whose heart vessels are dilated with a balloon (a procedure known as percutaneous coronary intervention where a small tube or stent is implanted to improve the blood flow to the heart). It is a possibly with implantation of a small tube (stent), to improve the blood flow to the heart. AGGRIBLOC INJECTION is not recommended for use in patients who have a history of bleeding, stroke with bleeding within last 30 days, history of bleeding in the brain, brain tumour or abnormal blood vessels in the brain, severe uncontrolled high blood pressure (malignant hypertension), severe liver disease, low platelet count (thrombocytopenia) either in current situation or as a previous encounter to usage of Tirofiban.

    Before receiving AGGRIBLOC INJECTION inform your doctor if you have or had any medical problems, allergies, cardiopulmonary resuscitation (CPR), biopsy, serious injury or major surgery, ulcer in the stomach or intestine within the last 3 months, bleeding disorder within 1 year, recent spinal procedure, history or symptoms of splitting of the aorta, uncontrolled high blood pressure, inflammation of the heart lining or blood vessels, disorder of the blood vessels in the back of the eye, kidney problems, heart failure, unusually low blood pressure due to heart failure, liver disorder, or low blood count.

    AGGRIBLOC INJECTION is not recommended during pregnancy. Contact your doctor before receiving. The most common side effects of AGGRIBLOC INJECTION are bleeding post-surgery under the skin at the site of the injection causing swelling, small red bruises on the skin, invisible blood in urine or stool, nausea, or headache. Contact your doctor if you experience any of the above side effects or persists for a longer duration.

    Uses Of AGGRIBLOC INJECTION

    It is used:

    • to assist the blood flow to the heart and manage chest pain and heart attack
    • in patients whose heart vessels are dilated with a balloon (a procedure known as percutaneous coronary intervention where a small tube or stent is implanted to improve the blood flow to the heart)

    How AGGRIBLOC INJECTION Works

    AGGRIBLOC INJECTION is a reversible antagonist of fibrinogen that binds to the glycoprotein (GP) IIb/IIIa receptor, the major platelet surface receptor involved in platelet aggregation. It works by managing platelets, cells found in the blood, from forming blood clots.

    How to use AGGRIBLOC INJECTION

    AGGRIBLOC INJECTION will be administered intravenously by your doctor or nurse only. Dose and duration will be decided by your physician depending upon your age, body weight and disease condition.

    Side Effects Of AGGRIBLOC INJECTION

    Common

    • bleeding post surgery
    • bleeding under the skin at the site of an injection, or into a muscle, causing swelling
    • small red bruises on the skin
    • invisible blood in urine or stool
    • nausea
    • headache
    • blood in urine or while coughing
    • bleeding in the nose, gums, and mouth or from the puncture site
    • reduction in red blood cells
    • decreases in platelet count
    • fever

    Uncommon

    • bleeding in the stomach or intestines
    • vomiting of blood

    Stop receiving AGGRIBLOC INJECTION and contact your doctor immediately if you experience any of the following side effects:

    • signs of bleeding in the skull such as headache, sensory impairments (visual or hearing), speech difficulties, numbness or difficulty in movement or balance
    • signs of internal bleeding such as coughing up blood or blood in urine or stool
    • signs of serious allergic reactions such as breathing difficulty and dizziness

    How To Manage Side Effects

    Nausea And Vomiting

    Take this medicine with, or just after meals. Stick to simple meals. Avoid eating rich or spicy food.

    Warning & Precautions

    Pregnancy

    Contraindicated

    AGGRIBLOC INJECTION is not recommended for use in pregnancy. Contact your doctor before receiving.

    Breastfeeding

    Consult your doctor

    It is not known whether AGGRIBLOC INJECTION is excreted in human milk. Your doctor will decide whether to discontinue breastfeeding or to discontinue the medicine. Contact your doctor before receiving.

    Driving and Using Machines

    Use with Caution

    Do not drive or operate machines while receiving AGGRIBLOC INJECTION. Contact your doctor before receiving.

    Kidney

    Use with Caution

    AGGRIBLOC INJECTION should be used with caution in patients with severe kidney disease. Contact your doctor before receiving.

    Liver

    Consult your doctor

    AGGRIBLOC INJECTION is not recommended for use in patients with severe liver disease. Contact your doctor before receiving. It should be used with caution in patients with liver disorder. Contact your doctor before receiving.

    Allergy

    Contraindicated

    Do not receive AGGRIBLOC INJECTION if you are allergic to Tirofiban or any of the other ingredients of this medicine.

    Heart Disease

    Consult your doctor

    AGGRIBLOC INJECTION is not recommended for use in patients with severe uncontrolled high blood pressure (malignant hypertension). AGGRIBLOC INJECTION should be used with caution in patients with history or symptoms of splitting of the aorta, uncontrolled high blood pressure, inflammation of the heart lining or blood vessels, heart failure, unusually low blood pressure due to heart failure. Contact your doctor before receiving.

    Use In Pediatrics

    Consult your doctor

    AGGRIBLOC INJECTION is not recommended for use in children and adolescents under 18 years of age as safety and effectiveness in children have not established. Contact your doctor before receiving.

    Others

    AGGRIBLOC INJECTION is not recommended for use if you have:

    • history of bleeding in the brain, abnormal blood vessels in the brain
    • low platelet count (thrombocytopenia) either in current situation or as a previous encounter to usage of Tirofiban

    Before receiving AGGRIBLOC INJECTION tell your doctor if you have or had:

    • any other medical problems
    • cardiopulmonary resuscitation (CPR)
    • biopsy, serious injury or major surgery
    • ulcer in the stomach or intestine within the last 3 months
    • recent spinal procedure
    • disorder of the blood vessels in the back of the eye
    • low blood count

    Interactions

    A. Drug-Drug Interactions:

    Before receiving AGGRIBLOC INJECTION, inform your doctor if you are taking any of the following medicine:

    • warfarin (medicine used to manage blood clot)

    Overdosage:

    It is unlikely to cause overdose, AGGRIBLOC INJECTION will be administered into your vein only by a doctor or nurse.

    Synopsis

    Drug :   Tirofiban
    Pharmacological Category :   Platelet Aggregation Inhibitors
    Therapeutic Indication :   Assist the blood flow to the heart and manage chest pain and heart attacks
    Dosage Forms :   Injection

    More Information

    • Keep AGGRIBLOC INJECTION out of the sight and reach of children
    • Store AGGRIBLOC INJECTION at room temperature

    FAQs About AGGRIBLOC INJECTION

    Q: How should I use AGGRIBLOC INJECTION?

    A: AGGRIBLOC INJECTION will be administered into a vein by your doctor or nurse only. Dose and duration will be decided by your physician depending upon your age, body weight and disease condition.

    Q: How does AGGRIBLOC INJECTION work?

    A: AGGRIBLOC INJECTION is a reversible antagonist of fibrinogen that binds to the glycoprotein (GP) IIb/IIIa receptor, the major platelet surface receptor involved in platelet aggregation. It works by managing platelets, cells found in the blood, from forming blood clots.

    Q: What is the use of AGGRIBLOC INJECTION?

    A: It is used to assist the blood flow to the heart and manage chest pain and heart attacks. It may also be used in patients whose heart vessels are dilated with a balloon (a procedure known as percutaneous coronary intervention where a small tube or stent is implanted to improve the blood flow to the heart).

    Q: What are the contraindications of AGGRIBLOC INJECTION?

    A: AGGRIBLOC INJECTION is not recommended for use in patients who have a history of bleeding (internal or external), stroke, history of bleeding in the brain, brain tumour or abnormal blood vessels in the brain, severe uncontrolled high blood pressure (malignant hypertension), severe liver disease, low platelet count (thrombocytopenia) either in current situation or as a previous encounter to usage of Tirofiban.

    Q: What will happen if I receive extra dose of AGGRIBLOC INJECTION?

    A: AGGRIBLOC INJECTION will be administered into your vein only by a doctor or nurse in a proper healthcare setup so chances of overdose are minimal. If you are accidentally given extra dose of AGGRIBLOC INJECTION the most common symptom may be bleeding. Contact your doctor immediately.

    Q: What are the common side effects of AGGRIBLOC INJECTION?

    A: The most common side effects of AGGRIBLOC INJECTION are bleeding post-surgery under the skin at the site of the injection causing swelling, small red bruises on the skin, invisible blood in urine or stool, nausea, or headache. Contact your doctor if you experience any of the side effects.

    References

    1. K.D. Tripathi. Essentials of Medical Pharmacology. 7th edition. 2013. Drugs Affecting Blood and Blood Formation. Page 631.

    2. Cuihua Zhao. Guanchang Cheng. Ruili He. Hongyu Guo. Yanming Li. Xueli Lu. Yuan Zhang. Chunguang Qiu. Effects of different routes of tirofiban injection on the left ventricular function and prognosis of patients with myocardial infarction treated with percutaneous coronary intervention. [Published in April 2015] [Accessed on 11th March 2023] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473353/

    3. Lili Sun. Jinping Zhang. Yun Song. Wei Zhao. Meimei Zheng. Jun Zhang. Hao Yin. Wei Wang. Yao Meng. Jiyou Tang. Ju Han. Safety and Efficacy of Tirofiban in Rescue Treatment for Acute Intracranial Intraprocedural Stent Thrombosis [Accessed on 11th March 2023] https://www.frontiersin.org/articles/10.3389/fneur.2020.00492/full

    4. Arvato Distribution GmbH. Tirofiban. European Medicines Agency (EMA). [Revised in Aug 2022] [Accessed on 11th March 2023] https://www.medicines.org.uk/emc/files/pil.566.pdf

    5. Emergent Biosolutions. U.S. Food and Drugs Association (FDA). [Revised in December 2020] [Accessed on 11th March 2023] https://www.aggrastathdb.com/wp-content/uploads/2022/05/aggrastat-pharmacy-prescribing-information.pdf

    6. Altan Pharmaceuticals. Tirofiban. Electronic Medicines Compendium (EMC). [Revised in Feb 2020] [Accessed on 11th March 2023] https://www.medicines.org.uk/emc/files/pil.8842.pdf

    7. Biocon Limited. Tirofiban. [Accessed on 11th March 2023] https://biocon.com/docs/prescribing_information/cardiology/tirozest_pi.pdf

    Useful Diagnostic Tests

    • Complete Blood Count (CBC)
    • Electrocardiogram (ECG)

    Author Details

    Written By Dr. Janet.C - Pharm.D
    Reviewed For Accuracy By Dr. Thamada Manikanta Praveen - MBBS, MD (General Medicine)
    Last updated on 16 Mar 2023 | 05:56 PM(IST)
    Lab updated